Fig. 3
From: Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer
qPCR, WB, and IHC validation of ANKLE1, EMD, and LEMD2 in prostate cancer. A–C The mRNA levels of ANKLE1, EMD, and LEMD2 in human prostate tumor specimens were validated by qPCR. D–I The protein levels of ANKLE1, EMD, and LEMD2 in human prostate tumor specimens were validated by WB and IHC. The data (means ± SEM) shown (A–C, n = 5; D–I, n = 3) were representative of three separate experiments. Compared with the indicated group, *p < 0.05, **p < 0.01, ***p < 0.001